Carmell receives Nasdaq deficiency notice for bid price below $1; 180 days to cure

Longevity Health Holdings, Inc.

Nasdaq notified Carmell on Sept 30, 2024 that its common stock failed to maintain minimum $1 bid price for 31 consecutive business days.
Company has until March 31, 2025 to regain compliance; closing bid price must be $1 for at least 10 consecutive days.
If not cured, Nasdaq may grant an additional 180-day period if other listing standards are met.
No immediate impact on trading of common stock (CTCX) or warrants (CTCXW); company evaluating options.
There is no assurance that Carmell will be able to regain compliance with the Minimum Bid Price Requirement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.